Emotion perception impairment in schizophrenia represents a robust finding in schizophrenia that appears to be moderated by certain clinical and demographic factors. Future directions for research on emotion perception are discussed.

No abstract

. The Cibaliung gold project is located at the central portion of the Neogene Sunda‐Banda magmatic arc. Gold‐silver mineralization in the area is hosted in a thick sequence of sub‐aqueous basaltic andesite volcanics with intercalated sediments intruded by sub‐volcanic andesite to diorite plugs and dykes, and subsequently cut by a cluster of diatreme breccias. These host rocks are unconformably overlain by dacitic tuffs, younger sediments and basalt flows. The gold prospects in Cibaliung occur within a NW‐trending structural corridor that is 3.5 km wide by at least 6 km long. It is fault‐bounded and is considered to be a graben. Two aligned NNW‐trending sub‐vertical shoots, Cikoneng and Cibitung, host the currently defined resource within the steeply dipping vein system with a minimum strike length of 1,300 m. As of July 2001, exploration has defined an inferred + indicated mineral resource of approximately 1.3 million tonnes at 10.42 g/t gold and 60.7 g/t silver at a 3 g/t Au cut‐off. This equates to approximately 435,000 ounces of gold and 2.54 million ounces of silver. Gold‐silver mineralization occurs as quartz veins characteristic of the low‐sulphidation epithermal adularia‐sericite type. Progressive dilation with a general increase in gold grade has produced multi‐stage veining and brecciation that grades from early to late stages as: pre‐mineral fluidized breccia, quartz vein stockwork, massive vein, crustiform vein, colloform‐crustiform vein with progressive increase in chloritic clay bands, clay‐quartz milled matrix breccias with a progressive increase in clay content, and synto post‐mineral fault gouge with vein clasts. Wall rock alteration is characterized by pro‐grade chlorite+adularia flooding that is locally overprinted by a low temperature argillic alteration (smectite, illite and mixed layered clays). Generally, the argillic alteration becomes weak with depth. The major mineral constituents of the veins are quartz, adularia and clay. In the early gold‐poor hydrothermal stages, quartz and adularia dominate with minor calcite and clay (smectite, poorly crystalline chlorite, interlayered chlorite‐smectite and illite‐smectite). In the later gold‐rich hydrothermal stages, clay with variable amounts of carbonate increases whereas the abundance of quartz and adularia decreases. Gold occurs mainly as electrum while silver occurs as argentite‐aguilarite‐naumannite and electrum, and rarely as native silver, sulphosalts and tellurides. Sulphides generally comprise <1 vol % of the vein, with pyrite as the most common species. Together with pyrite, traces of very fine‐grained base metal sulphides dominated by chalcopyrite, sphalerite and galena are in most cases intimately associated with electrum and silver minerals. Partial supergene oxidation generally extends down to about 200 m below the surface at Cikoneng and further down to more than 300 m at Cibitung. The hydrothermal system responsible for the gold‐silver mineralization in the area may be related to rhyolitic magmatism focused on a volcanic i...

Middle ear pressure (MEP) abnormalities are frequently observed during influenza virus infection and may serve as surrogate markers for the risk of otitis media. MEP abnormalities were evaluated in adult volunteers who were inoculated with influenza A/Texas/36/91(H1N1) or B/Yamagata/88 virus and given the antiviral zanamivir (GG167) intranasally as prophylaxis or early treatment in randomized, double-blind, placebo-controlled trials. In the influenza A prophylaxis studies, 15% of 61 zanamivir recipients versus 61% of 33 placebo recipients showed significant MEP abnormalities (P < .01). In the influenza A early treatment trial, 32% of 31 infected zanamivir recipients versus 73% of 26 infected placebo recipients developed MEP abnormalities (P < .01). In the influenza B prophylaxis trial, 16% of 25 zanamivir versus 44% of 9 placebo recipients showed abnormalities (P = .09). These findings indicate that the neuraminidase inhibitor zanamivir, which is effective in reducing experimental influenza illness, provides protection against the development of MEP abnormalities.